Skip to main content
ArticleOPEN ACCESS

Erratum: Will the reformed cancer drugs fund address the most common types of uncertainty? An analysis of NICE cancer drug appraisals (BMC Health Services Research (2018) 18 (393) DOI: 10.1186/s12913-018-3162-2)

BMC Health Services Research
DOI: 10.1186/s12913-019-4039-8
1Citations
Citations of this article
1Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

In the original publication of this article [1], the Acknowledgements section lacks of important funding information "This project was funded by the NIHR Oxford Biomedical Research Centre BRC". The authors apologize for any inconvenience that it may have caused.

Cite

CITATION STYLE

APA

Morrell, L., Wordsworth, S., Schuh, A., Middleton, M. R., Rees, S., & Barker, R. W. (2019, March 28). Erratum: Will the reformed cancer drugs fund address the most common types of uncertainty? An analysis of NICE cancer drug appraisals (BMC Health Services Research (2018) 18 (393) DOI: 10.1186/s12913-018-3162-2). BMC Health Services Research. BioMed Central Ltd. https://doi.org/10.1186/s12913-019-4039-8

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free